| Literature DB >> 28585395 |
Olesya Solheim1, Mette Førsund2, Claes G Tropé3, Sigrid Marie Kraggerud4,5, Jahn M Nesland2,3, Ben Davidson2,3.
Abstract
The purpose of this study was to determine the expression and potential clinical role of epithelial-to-mesenchymal transition (EMT)-related factors in malignant ovarian germ cell tumors (MOGCT). Protein expression of E-cadherin, N-cadherin, P-cadherin, Zeb1, HMGA2, and vimentin by immunohistochemistry was analyzed in 42 MOGCT from patients treated in Norway during the period 1981-2001. Expression was analyzed for association with clinicopathologic parameters. E-cadherin (p = 0.016) and HMGA2 (p = 0.002) expression was significantly higher in immature teratomas and yolk sac tumors compared with dysgerminomas. Vimentin (p < 0.001) and Zeb1 (p = 0.029) staining was significantly higher in immature teratomas compared with yolk sac tumors and dysgerminomas, whereas no significant differences were observed for N-cadherin and P-cadherin. EMT-associated markers were not significantly related to clinicopathologic parameters including age, tumor diameter, and FIGO stage. In conclusion, based on this limited series, EMT-associated markers are not associated with clinical parameters in MOGCT, in contrast to ovarian carcinoma. EMT-related proteins are differentially expressed among various MOGCT subtypes, suggesting differences in biological characteristics associated with invasion and metastasis.Entities:
Keywords: Ovary; epithelial-to-mesenchymal transition; immunohistochemistry; malignant germ cell tumor; tumor progression
Mesh:
Substances:
Year: 2017 PMID: 28585395 DOI: 10.1111/apm.12715
Source DB: PubMed Journal: APMIS ISSN: 0903-4641 Impact factor: 3.205